IL6 and gastric cancer: We show that CAFs derived-IL-6 promoted the migration and EMT of gastric cancer cells via the activation of JAK2-STAT3 pathway, and blocking this pathway with IL-6 neutralizing antibody or JAK2 specific inhibitor AG490 impaired gastric cancer metastasis induced by CAFs in vivo.